VICO Analyst Estimates: Price Targets, Revenue, Net Income, and EBIT Forecast - Vicore Pharma Holding AB - Alpha Spread

Vicore Pharma Holding AB
STO:VICO

Watchlist Manager
Vicore Pharma Holding AB Logo
Vicore Pharma Holding AB
STO:VICO
Watchlist
Price: 7.17 SEK 0.99% Market Closed
Market Cap: 801.1m SEK
Have any thoughts about
Vicore Pharma Holding AB?
Write Note

Wall Street
Price Targets

VICO Price Targets Summary
Vicore Pharma Holding AB

Wall Street analysts forecast VICO stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for VICO is 51 SEK with a low forecast of 40.4 SEK and a high forecast of 73.5 SEK.

Lowest
Price Target
40.4 SEK
463% Upside
Average
Price Target
51 SEK
611% Upside
Highest
Price Target
73.5 SEK
925% Upside
Vicore Pharma Holding AB Competitors:
Price Targets
PHM
Pharma Mar SA
15% Upside
SKYE
Skye Bioscience Inc
222% Upside
BPMC
Blueprint Medicines Corp
41% Upside
CASI
CASI Pharmaceuticals Inc
9% Downside
4593
Healios KK
28% Upside
ALEC
Alector Inc
128% Upside
RCUS
Arcus Biosciences Inc
105% Upside

Revenue
Forecast

Revenue Estimate
Vicore Pharma Holding AB

N/A
Past Growth
N/A
Estimated Growth
N/A
Estimates Accuracy
N/A
Average

Operating Income
Forecast

Operating Income Estimate
Vicore Pharma Holding AB

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-10%
Average Miss

Net Income
Forecast

Net Income Estimate
Vicore Pharma Holding AB

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-43%
Average Miss

See Also

Discover More
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is VICO's stock price target?
Price Target
51 SEK

According to Wall Street analysts, the average 1-year price target for VICO is 51 SEK with a low forecast of 40.4 SEK and a high forecast of 73.5 SEK.

Back to Top